Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Vitamin D Deficiency 3 Prostatic Neoplasms 3 Leukemia, Lymphocytic, Chronic, B-Cell 2 Triple Negative Breast Neoplasms 1 Subcutaneous panniculitis-like T-cell lymphoma 1 Psoriasis 1 Osteoporosis Secondary 1 Osteoarthritis 1 Obesity 1 Neoplasms 1 Lymphoma, T-Cell 1 Lymphoma, Primary Cutaneous Anaplastic Large Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Extranodal NK-T-Cell 1 Immunoblastic Lymphadenopathy 1 Fractures, Stress 1 Enteropathy-Associated T-Cell Lymphoma 1 Colorectal Adenocarcinoma 1 Colonic Neoplasms 1 Cardiovascular Diseases 1 Carcinoma, Intraductal, Noninfiltrating 1 Bone Metabolism Biomarkers 1 Autoimmune Diseases 1 Arthritis, Rheumatoid 1

Interventions

Cholecalciferol 1 Calcium Carbonate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Osteoporosis Secondary × Cholecalciferol × 1 year × Clear all

NCT07256769 2025-12-01

Synostea

Regina Elena Cancer Institute

Osteoporosis Secondary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡